Bone Biologics Co. (OTC:BBLG – Get Free Report) traded up 13% during trading on Friday . The stock traded as high as $1.19 and last traded at $1.11. 375,913 shares traded hands during trading, an increase of 41% from the average session volume of 265,956 shares. The stock had previously closed at $0.98.
Bone Biologics Trading Up 13.0 %
The firm has a 50 day moving average of $1.19 and a two-hundred day moving average of $1.45. The stock has a market capitalization of $2.77 million, a PE ratio of -0.02 and a beta of 0.45.
About Bone Biologics
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.
Featured Stories
- Five stocks we like better than Bone Biologics
- What Are Dividend Champions? How to Invest in the Champions
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- How to Most Effectively Use the MarketBeat Earnings Screener
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Conference Calls and Individual Investors
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Bone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
